US Stock MarketDetailed Quotes

Nuvectis Pharma (NVCT)

Watchlist
  • 8.900
  • +0.550+6.59%
Close Apr 17 16:00 ET
  • 8.900
  • 0.0000.00%
Post 20:01 ET
235.78MMarket Cap-6.74P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nuvectis Pharma (NVCT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-30.72%-16.01M
-61.22%-3.97M
-86.94%-4.49M
-11.49%-3.37M
4.22%-4.17M
23.24%-12.25M
35.97%-2.47M
25.89%-2.4M
26.03%-3.02M
8.77%-4.36M
Net income from continuing operations
-39.17%-26.44M
-17.06%-7.31M
-79.68%-7.46M
-43.04%-6.33M
-27.84%-5.33M
14.65%-19M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
Change In working capital
132.24%4.4M
-29.45%1.86M
156.10%1.51M
746.58%1.24M
85.84%-210K
18.36%1.9M
70.23%2.64M
-60.77%590K
-78.37%146K
30.38%-1.48M
-Change in payables and accrued expense
1,907.24%3.05M
-114.47%-115K
294.06%1.53M
526.34%1.64M
--0
-87.82%152K
-43.54%795K
-71.67%387K
-5.07%262K
28.30%-1.29M
-Change in other current assets
93.33%-1K
9.38%70K
56.82%69K
2.94%70K
-9.95%-210K
-104.25%-15K
-55.56%64K
-68.12%44K
-82.96%68K
41.77%-191K
-Change in other working capital
-23.15%1.35M
7.07%1.91M
-152.20%-83K
----
----
--1.76M
--1.78M
--159K
----
----
Cash from discontinued investing activities
Operating cash flow
-30.72%-16.01M
-61.22%-3.97M
-86.94%-4.49M
-11.49%-3.37M
4.22%-4.17M
23.24%-12.25M
35.97%-2.47M
25.89%-2.4M
26.03%-3.02M
8.77%-4.36M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
149.79%29.11M
-95.66%166K
802.06%13.14M
-82.30%296K
230.17%15.51M
-22.75%11.65M
317.56%3.83M
107.25%1.46M
-87.35%1.67M
1,763.49%4.7M
Net common stock issuance
159.31%31.21M
-93.73%248K
799.14%13.55M
-64.45%614K
246.42%16.8M
127.57%12.04M
338.73%3.95M
33.84%1.51M
-47.06%1.73M
--4.85M
Proceeds from stock option exercised by employees
----
----
----
----
----
--0
--0
--0
--0
--0
Net other financing activities
-449.74%-2.1M
33.87%-82K
-714.00%-407K
-478.18%-318K
-745.10%-1.29M
72.60%-382K
-875.00%-124K
88.56%-50K
89.48%-55K
66.00%-153K
Cash from discontinued financing activities
Financing cash flow
149.79%29.11M
-95.66%166K
802.06%13.14M
-82.30%296K
230.17%15.51M
-22.75%11.65M
317.56%3.83M
107.25%1.46M
-87.35%1.67M
1,763.49%4.7M
Net cash flow
Beginning cash position
-3.10%18.53M
106.43%35.44M
47.90%26.79M
53.43%29.86M
-3.10%18.53M
-4.34%19.13M
-22.17%17.17M
-26.36%18.12M
25.83%19.46M
-4.34%19.13M
Current changes in cash
2,309.27%13.1M
-379.18%-3.81M
1,013.31%8.65M
-127.82%-3.07M
3,252.37%11.33M
31.60%-593K
146.51%1.36M
62.73%-947K
-114.76%-1.35M
107.47%338K
End cash Position
70.69%31.63M
70.69%31.63M
106.43%35.44M
47.90%26.79M
53.43%29.86M
-3.10%18.53M
-3.10%18.53M
-22.17%17.17M
-26.36%18.12M
25.83%19.46M
Free cash flow
-30.72%-16.01M
-61.22%-3.97M
-86.94%-4.49M
-11.49%-3.37M
4.22%-4.17M
23.24%-12.25M
35.97%-2.47M
25.89%-2.4M
26.03%-3.02M
8.77%-4.36M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -30.72%-16.01M-61.22%-3.97M-86.94%-4.49M-11.49%-3.37M4.22%-4.17M23.24%-12.25M35.97%-2.47M25.89%-2.4M26.03%-3.02M8.77%-4.36M
Net income from continuing operations -39.17%-26.44M-17.06%-7.31M-79.68%-7.46M-43.04%-6.33M-27.84%-5.33M14.65%-19M5.65%-6.25M29.38%-4.15M22.42%-4.43M-3.01%-4.17M
Change In working capital 132.24%4.4M-29.45%1.86M156.10%1.51M746.58%1.24M85.84%-210K18.36%1.9M70.23%2.64M-60.77%590K-78.37%146K30.38%-1.48M
-Change in payables and accrued expense 1,907.24%3.05M-114.47%-115K294.06%1.53M526.34%1.64M--0-87.82%152K-43.54%795K-71.67%387K-5.07%262K28.30%-1.29M
-Change in other current assets 93.33%-1K9.38%70K56.82%69K2.94%70K-9.95%-210K-104.25%-15K-55.56%64K-68.12%44K-82.96%68K41.77%-191K
-Change in other working capital -23.15%1.35M7.07%1.91M-152.20%-83K----------1.76M--1.78M--159K--------
Cash from discontinued investing activities
Operating cash flow -30.72%-16.01M-61.22%-3.97M-86.94%-4.49M-11.49%-3.37M4.22%-4.17M23.24%-12.25M35.97%-2.47M25.89%-2.4M26.03%-3.02M8.77%-4.36M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 149.79%29.11M-95.66%166K802.06%13.14M-82.30%296K230.17%15.51M-22.75%11.65M317.56%3.83M107.25%1.46M-87.35%1.67M1,763.49%4.7M
Net common stock issuance 159.31%31.21M-93.73%248K799.14%13.55M-64.45%614K246.42%16.8M127.57%12.04M338.73%3.95M33.84%1.51M-47.06%1.73M--4.85M
Proceeds from stock option exercised by employees ----------------------0--0--0--0--0
Net other financing activities -449.74%-2.1M33.87%-82K-714.00%-407K-478.18%-318K-745.10%-1.29M72.60%-382K-875.00%-124K88.56%-50K89.48%-55K66.00%-153K
Cash from discontinued financing activities
Financing cash flow 149.79%29.11M-95.66%166K802.06%13.14M-82.30%296K230.17%15.51M-22.75%11.65M317.56%3.83M107.25%1.46M-87.35%1.67M1,763.49%4.7M
Net cash flow
Beginning cash position -3.10%18.53M106.43%35.44M47.90%26.79M53.43%29.86M-3.10%18.53M-4.34%19.13M-22.17%17.17M-26.36%18.12M25.83%19.46M-4.34%19.13M
Current changes in cash 2,309.27%13.1M-379.18%-3.81M1,013.31%8.65M-127.82%-3.07M3,252.37%11.33M31.60%-593K146.51%1.36M62.73%-947K-114.76%-1.35M107.47%338K
End cash Position 70.69%31.63M70.69%31.63M106.43%35.44M47.90%26.79M53.43%29.86M-3.10%18.53M-3.10%18.53M-22.17%17.17M-26.36%18.12M25.83%19.46M
Free cash flow -30.72%-16.01M-61.22%-3.97M-86.94%-4.49M-11.49%-3.37M4.22%-4.17M23.24%-12.25M35.97%-2.47M25.89%-2.4M26.03%-3.02M8.77%-4.36M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -